RECENT ADVANCEMENT IN THE MANAGEMENT OF PNEUMONIA
Keywords:
Biomarkers, procalcitonin, recent advancement, novel antimicrobial therapies, antimicrobial therapies.Abstract
Pneumonia is an infection in your lungs caused by bacteria, viruses or fungi. Pneumonia causes your lung tissue to swell (inflammation) and can cause fluid or pus in your lungs. Bacterial pneumonia is usually more severe than viral pneumonia, which often resolves on its own. Pneumonia can affect one or both lungs. Pneumonia in both of your lungs is called bilateral or double pneumonia.
References
REFERENCE
• Govindan, S.; Hyzy, R.C. The 2016 Guidelines for Hospital-acquired and Ventilator-associated Pneumonia
• Poole, S.; Clark, T.W. Rapid syndromic molecular testing in pneumonia: The current landscape and future potential. J. Infect 2020,80, 1–7
• Unyvero. Unyvero Lower Respiratory. Available online: https://www.opgen.com/wp-content/uploads/2022/04/PN3677D.pdf (accessed on 11 November 2024)
• High, J.; Enne, V.I.; Barber, J.A.; Brealey, D.; Turner, D.A.; Horne, R.; Peters, M.; Dhesi, Z.; Wagner, A.P.; Pandolfo, A.M.; et al.
• Niederman, M.S.; Torres, A. Severe community-acquired pneumonia. Eur. Respir. Rev. 2022,31, 220123
• Chahine, E.B.; Sucher, A.J. Lefamulin: The First Systemic Pleuromutilin Antibiotic. Ann. Pharmacother. 2020,54, 1203–1214.
